The EU’s medicines regulator says there is no indication that the Oxford-AstraZeneca Covid-19 vaccine is linked to an increased risk of blood clots.
It said the number of cases in vaccinated people was no higher than in the general population.
The statement came after a number of countries, including Denmark and Norway, suspended the use of the jab.
The suspension followed reports that a small number of people had developed clots after receiving the vaccine.
